Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Andexxa Lawsuit Andexxa recall lawsuits are being investigated after the FDA linked the drug to an increased risk of thrombotic events, including stroke, heart attack, pulmonary embolism, and fatal blood clots.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Premature Infant NEC Lawsuit Filed Against Makers of Cow’s Milk-Based Similac, Enfamil Formulas The baby’s entire intestinal tract was necrotic due to the side effects of premature infant NEC, allegedly caused by consuming Similac and Enfamil February 8, 2022 Irvin Jackson Add Your Comments The mother of a premature infant who died of necrotizing enterocolitis (NEC) after being fed cow’s milk-based infant formula has filed a lawsuit against the manufacturers of Similac and Enfamil, alleging they knew about serious risks associated with their products, but failed to require that new parents were warned. The complaint (PDF) was filed this week by Samantha Clarke, in the U.S. District Court for the Eastern District of Missouri, pursuing damages against Abbott Laboratories, the makers of Similac, and Mead Johnson & Company, the makers of Enfamil, as defendants. The wrongful death lawsuit was brought on behalf of Clarke and her daughter, Phoenix Jeffries, who was born premature last September. The child was fed both Similac and Enfamil baby formula while hospitalized, and developed the gastrointestinal illness NEC, which has been directly linked to use of cow’s milk formula instead of breastmilk. However, according to the lawsuit, Abbott Laboratories and Mead Johnson failed to disclose known information about the risks. BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION “On September 21, 2021, Phoenix Jeffries endured an exploratory laparotomy, which revealed Necrotizing Enterocolitis totalis, a condition where the entirety of the intestinal tract is necrotic and inoperable,” the lawsuit states. “At this point, Phoenix Jeffries was started on comfort care and Plaintiff Samantha Clarke and her family visited the NICU for the last hours of Phoenix Jeffries’ life. Phoenix Jeffries passed away from NEC shortly after.” Clarke’s lawsuit notes that the two manufacturers have known for years that their preterm infant formula products based on cow’s milk increased the risk of NEC, but have continued to promote them to hospitals, despite the premature infant NEC risks. NEC Risk for Premature Infants Fed Similac and Enfamil Formula Studies have shown that cow’s milk formula products like Similac and Enfamil cause NEC at substantially higher rates than is seen among premature babies fed breast milk or donor milk alone. However, the lawsuit maintains that Abbott Laboratories and Mead Johnson failed to provide adequate warnings or instructions about the risk. In a study published in November, Canadian researchers warned that preterm and low birth weight infants given cow’s milk-based formula were three times as likely to be transferred to a neonatal intensive care unit (NICU) for suspected NEC than those given donor milk. Similar findings were published in October in the medical journal Nutrients, which found that breast milk was the “gold standard” for nutritional support during infancy, with antimicrobial and bioactive factors which helped prevent NEC. Clarke now joins a growing number of families with premature infants diagnosed with NEC who are pursuing a Similac lawsuit or Enfamil lawsuit, each raising similar factual allegations and claims, indicating that marketing by the manufacturers caused these formulas to displace breast milk that infants would have otherwise received, robbing them of a primary defense against NEC. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Abbott Laboratories, Enfamil, Infant Death, Mead Johnson, Necrotizing Enterocolitis, Premature Birth, Similac Find Out If You Qualify for Infant Formula NEC Compensation More Baby Formula Lawsuit Stories Abbott Seeks Federal Protection From Similac NEC Lawsuits December 16, 2025 Similac Formula NEC Lawsuits Selected for Bellwether Trials in Aug. 2026, Nov. 2026 and Feb. 2027 November 11, 2025 Similac Lawsuit Claims Infant Formula Side Effects Led to Preemie’s Death October 27, 2025 2 Comments Samantha September 13, 2024 Phoenix is my baby. Today is her birthday, she would be 3. Happy birthday sweet girl Keri February 13, 2022 My baby see a G.I. specialist at Children’s Hospital. He’s a twin at birth he feed slow he gradually staring falling behind his brother by a pound then 2,3,4,5 pounds behind him URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: yesterday) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025) Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (Posted: 2 days ago) Several major recalls that occurred over the last two years are expected to have a significant impact on medical device and drug litigation throughout 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025) Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 1 week ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITTop Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)
Similac Formula NEC Lawsuits Selected for Bellwether Trials in Aug. 2026, Nov. 2026 and Feb. 2027 November 11, 2025
Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: yesterday) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)
Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (Posted: 2 days ago) Several major recalls that occurred over the last two years are expected to have a significant impact on medical device and drug litigation throughout 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)
Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 1 week ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITTop Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)